• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • New fees, tests and document requirements for DMF registration of APIs

New fees, tests and document requirements for DMF registration of APIs

Wednesday, 01 April 2020 / Published in News, Pharmaceuticals & DMF

New fees, tests and document requirements for DMF registration of APIs

There has been a recent and important change regarding the DMF (Drug Master File) registration of APIs (Active Pharmaceutical Ingredients) in China.

The NMPA (National Medical Products Administration, formerly CFDA) notice was published on 17th January 2020. A new online application system was implemented on 17th January 2020. It includes a new registration form.

There is the possibility that the NMPA introduced these changes in order to charge API DMF separately from final pharmaceutical products. An official application fee of RMB 367,600.00 was introduced. No official announcement containing detailed payment instructions, such as price and payment target, have yet been issued.

The process of API DMF is shown simplified below:
• Application for DMF number
• Preparation of all required technical documents
• Submission of the complete application dossier to CDE (Center for Drug Evaluation)
• CDE’s approval and online status “I”, which is made visible online.

The process for the “Bundle Technical Review” is shown simplified below:
• Payment of application fee for API (new requirement)
• Performance of registration test for API in China (new requirement)
• Receipt of test report, which is directly transferred from the test laboratory to the CDE
• Start of “Bundle Technical Review” together with the final pharmaceutical product
• Receipt of supplementary notice
• Preparation and submission of supplementary dossier
• CDE’s final approval and online status “A”

Tagged under: Active Pharmaceutical Ingredients, API, Bundle Technical Review, DMF, Drug Master File

What you can read next

Cisema experts cited in drug-device combination news
Guidelines for the Information Submission of Cosmetics Registration and Filing (Trial Version)
Regulatory Updates for Intravascular Catheters in September 2021

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.